Get In Touch

Market News

Influenza Vaccination Market Size, Share, Trends, Growth, Forecast Analysis Report 2019 By Product, By Application, By Segment, By Region – Global Forecast To 2025

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. “Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most …

Influenza Vaccination Market Size, Share, Trends, Growth, Forecast Analysis Report 2019 By Product, By Application, By Segment, By Region – Global Forecast To 2025 Read More »

Global Influenza Vaccines Market: Development History, Current Analysis and Estimated Forecast to 2025

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025. “Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most …

Global Influenza Vaccines Market: Development History, Current Analysis and Estimated Forecast to 2025 Read More »

Global Molecular Diagnostics Market Research Report, Size, Market Drivers and Key Players Strategies Analyzed Till 2021 / Key Players Roche, Abbott Laboratories, Qiagen etc.

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, …

Global Molecular Diagnostics Market Research Report, Size, Market Drivers and Key Players Strategies Analyzed Till 2021 / Key Players Roche, Abbott Laboratories, Qiagen etc. Read More »

vaccine market

New reports project strong growth for US Vaccine Market

DPI Research offers a latest published report on United States Vaccines Market 2019 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 Pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.  United States vaccines market …

New reports project strong growth for US Vaccine Market Read More »

flu vaccine

US Influenza Vaccines Market Rapid Growth and Status Detailed in a Recent Research Report

DPI Research offers a latest published report on United States Influenza Vaccines Market Report, Analysis and Forecast to 2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 130 Pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing …

US Influenza Vaccines Market Rapid Growth and Status Detailed in a Recent Research Report Read More »

Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US

The US Food and Drug Administration (FDA) recently approved pharma giants Sanofi and Merck’s Vaxelis, a new pediatric vaccine against six diseases. The vaccine will help to bolster vaccination rates across the US by reducing the shot burden on infants and children, according to GlobalData, a leading data and analytics company. Vaxelis, which is indicated …

Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US Read More »

Zydus receives USFDA approval for skin, heart drugs

Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP, Amlodipine and Atorvastatin Tablets USP. Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD – DIPROLENE® AF), 0.05%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. …

Zydus receives USFDA approval for skin, heart drugs Read More »

Why are workers in Bangladesh’s garment industry worried about safety?

Source: https://www.business-standard.com/article/international/why-are-workers-in-bangladesh-s-garment-industry-worried-about-safety-119010900229_1.html In April 2013, a garments factory collapse at the Rana Plaza building in Savar, Bangladesh, left 1,134 people dead. The tragedy exposed the lack of safety of Bangladesh’s garment industry, the country’s biggest employer and leading export business, whose clientele includes huge European and US fashion brands. In its wake, over 180 international retailers, importers, …

Why are workers in Bangladesh’s garment industry worried about safety? Read More »